skip to main content

Bone Marrow Transplant

Revised understanding of graft-versus-host disease origins offers new direction for potential therapies

An international research team led by the University of Michigan Life Sciences Institute is changing the understanding of the key cellular and molecular events that trigger graft-versus-host disease, an often-fatal complication of bone marrow transplants.

Leukemia Clinical Studies

Below is a list of open trials. If you have questions or are interested in any of the studies, please contact Cancer AnswerLine™ at 800-865-1125

Newly identified proteins make promising targets for blocking graft-vs.-host disease

Researchers from the University of Michigan Rogel Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants.

Pages